As of April 2024 VistaGen Therapeutics has a market cap of $0.12 Billion. This makes VistaGen Therapeutics the world's 7238th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.12 B | -6.8% |
2023 | $0.13 B | 551.98% |
2022 | $21.3 M | -94.53% |
2021 | $0.38 B | 46.35% |
2020 | $0.26 B | 792.58% |
2019 | $29.81 M | -36.01% |
2018 | $46.58 M | 91.5% |
2017 | $24.32 M | -22.17% |
2016 | $31.25 M | 73.63% |
2015 | $18 M | 59.82% |
2014 | $11.26 M | 18.76% |
2013 | $9.48 M | -32.86% |
2012 | $14.12 M | -71.19% |
2011 | $49.02 M |
On Apr 25th, 2024 the market cap of VistaGen Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.53 B | 316.90% | ๐บ๐ธ USA |